| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8418758 | Journal of Immunological Methods | 2012 | 10 Pages |
Abstract
In this study three robust systems biology-oriented biomarkers for the monitoring of SAR were computed that demonstrated small to moderate improvement compared to monitoring of a single cytokine (IL-10 (day 7)) (CV correct improvement: 0.07 (total group), 0.04 (subcutaneous injection group), 0.16 (nasal spray group)). Further computation and biomarker validation with larger datasets, including data from healthy persons and SAR patients, are indicated.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Erik W. Baars, Andreas F.M. Nierop, Huub F.J. Savelkoul,